Literature DB >> 31874036

Heterobifunctional Molecules Induce Dephosphorylation of Kinases-A Proof of Concept Study.

Sayumi Yamazoe, Jeffrey Tom, Yue Fu, Wenqiong Wu1, Liang Zeng1, Changlei Sun1, Qi Liu1, Jie Lin, Kui Lin, Wayne J Fairbrother, Steven T Staben.   

Abstract

Heterobifunctional molecules have proven powerful tools to induce ligase-dependent ubiquitination of target proteins. We describe here a chemical strategy for controlling a different post-translational modification (PTM): phosphorylation. Heterobifunctional molecules were designed to promote the proximity of a protein phosphatase (PP1) to protein targets. The synthesized molecules induced the PP1-dependent dephosphorylation of AKT and EGFR. To our knowledge, this work represents the first examples of small molecules recruiting non-native partners to induce removal of a PTM.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31874036     DOI: 10.1021/acs.jmedchem.9b01167

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

Review 1.  Preclinical and Clinical Advances of Targeted Protein Degradation as a Novel Cancer Therapeutic Strategy: An Oncologist Perspective.

Authors:  Xinrui Yang; He Yin; Richard D Kim; Jason B Fleming; Hao Xie
Journal:  Target Oncol       Date:  2020-12-28       Impact factor: 4.493

2.  Intrinsically disordered linkers control tethered kinases via effective concentration.

Authors:  Mateusz Dyla; Magnus Kjaergaard
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-18       Impact factor: 11.205

3.  Protein-Protein Interaction Prediction for Targeted Protein Degradation.

Authors:  Oliver Orasch; Noah Weber; Michael Müller; Amir Amanzadi; Chiara Gasbarri; Christopher Trummer
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

4.  Deubiquitinase-targeting chimeras for targeted protein stabilization.

Authors:  Nathaniel J Henning; Lydia Boike; Jessica N Spradlin; Carl C Ward; Gang Liu; Erika Zhang; Bridget P Belcher; Scott M Brittain; Matthew J Hesse; Dustin Dovala; Lynn M McGregor; Rachel Valdez Misiolek; Lindsey W Plasschaert; David J Rowlands; Feng Wang; Andreas O Frank; Daniel Fuller; Abigail R Estes; Katelyn L Randal; Anoohya Panidapu; Jeffrey M McKenna; John A Tallarico; Markus Schirle; Daniel K Nomura
Journal:  Nat Chem Biol       Date:  2022-02-24       Impact factor: 16.174

Review 5.  Critical Assessment of Targeted Protein Degradation as a Research Tool and Pharmacological Modality.

Authors:  Milka Kostic; Lyn H Jones
Journal:  Trends Pharmacol Sci       Date:  2020-03-26       Impact factor: 14.819

Review 6.  PROTACs to address the challenges facing small molecule inhibitors.

Authors:  Pedro Martín-Acosta; Xiangshu Xiao
Journal:  Eur J Med Chem       Date:  2020-11-05       Impact factor: 6.514

Review 7.  Cancer therapies based on targeted protein degradation - lessons learned with lenalidomide.

Authors:  Max Jan; Adam S Sperling; Benjamin L Ebert
Journal:  Nat Rev Clin Oncol       Date:  2021-03-02       Impact factor: 66.675

8.  Ligandability of E3 Ligases for Targeted Protein Degradation Applications.

Authors:  Bridget P Belcher; Carl C Ward; Daniel K Nomura
Journal:  Biochemistry       Date:  2021-09-02       Impact factor: 3.162

Review 9.  Prey for the Proteasome: Targeted Protein Degradation-A Medicinal Chemist's Perspective.

Authors:  Laura M Luh; Ulrike Scheib; Katrin Juenemann; Lars Wortmann; Michael Brands; Philipp M Cromm
Journal:  Angew Chem Int Ed Engl       Date:  2020-07-30       Impact factor: 15.336

Review 10.  Turn and Face the Strange: A New View on Phosphatases.

Authors:  Maja Köhn
Journal:  ACS Cent Sci       Date:  2020-03-13       Impact factor: 14.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.